Newsbriefs

ICON has expanded early phase capabilities with the acquisition of Healthcare
Discoveries, Inc. in the US

ICON recently announced the acquisition of Healthcare Discoveries, an 85-bed clinical pharmacology unit in San Antonio, Texas, with significant experience in early phase development.

“The acquisition of Healthcare Discoveries is an important step for ICON,” said ICON CEO Peter Gray. “It gives us a clinical pharmacology platform in the United States to complement our existing European Phase I operations. As well as gaining an outstanding facility, we are bringing into ICON an experienced team that has an excellent market reputation.”

Healthcare Discoveries will become part of a comprehensive early phase development portfolio within the ICON Development Solutions division, which includes an existing 80-bed clinical pharmacology unit based in Manchester, England.

ICON Development Solutions, one of ICON’s five international divisions, specializes in the strategy, management and execution of product development and early phase clinical development. For further information, please go to www.iconplc.com.

ICON Development Solutions announces four key appointments

ICON recently announced four key appointments that will enhance the company’s ability to assist clients with Pharmacokinetic (PK) and Pharmacodynamic (PD), Modeling and Simulation services.